Democritus University of Thrace (DUTH)
Μελέτη της αγγειογένεσης και της απόπτωσης στον καρκίνο του όρχεως
Abstract
dc:descriptionAim: The measurement of growth factors in the serum of patients with testicular cancer and healthy controls and the comparison between these values, as well as the comparison between the three consecutive values of these variables in patients. We chose to study factors from pathways with proven role in carcinogenesis and to evaluate these factors for their potential prognostic or predictive role in patients with testicular cancer. Patients and Methods: 50 patients with histologically confirmed testicular germ cell tumor, after orchiectomy and before commencing chemotherapy and 16 healthy male controls were included in the study. Three blood samples were drawn, the first before the beginning of chemotherapy, the second one month after the completion of the second cycle of chemotherapy and the third one year after the completion of treatment. One blood sample was drawn from healthy controls. We measured and calculated in the serum samples of patients and healthy controls the following factors: a) Insulin like Growth Factor 1 (IGF-1) b) Insulin like Growth Factor Binding Protein 3 (IGFBP-3) c) IGF-1/IGFBP-3 molar ratio d) Matrix Metalloproteinase 2 (MMP-2) e) Matrix Metalloproteinase 9 (MMP-9) f) Tissue Inhibitor of Metalloproteinase 2 (TIMP-2) g) MMP-2/TIMP-2 ratio h) MMP-2/TIMP-2 ratio i) Vascular Endothelial Growth Factor A (VEGF-A) j) basic Fibroblast Growth Factor (bFGF) k) Platelet Derived Growth Factor BB (PDGF-BB) Results-Conclusions: Serum levels of the factors IGF-1, IGFBP-3, IGF-1/IGFBP-3 molar ratio, TIMP-2, MMP-2/TIMP-2 ratio, MMP-9/TIMP-2 ratio and PDGF-BB were initially abnormal in patients and normalized gradually, rendering these factors potentially useful as predictive factors of response to chemotherapy. Also, Ang-2 was initially lower in the good prognostic patient group and bFGF was initially lower in the patients with favorable outcome, something that could potentially be used as prognostic factor. The values of IGF-1/IGFBP-3 molar ratio, TIMP-2, MMP-2/TIMP-2 ratio, MMP-9/TIMP-2 ratio, showed initially statistically significant difference between patients and controls with early or late normalization, making these factors potentially useful for the follow up of the patients. Finally, Ang-2 values were higher in patients than normal controls and have not normalized, even one year after the completion of chemotherapy, making appealing the idea of correlating these high values with the long term increased cardiovascular morbidity of testicular cancers survivors, considering the role of angiopoietin pathway in tissue ischemia. This hypothesis merits further evaluation.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Διαμαντόπουλος, Νικόλαος
- Diamantopoulos, Nikolaos
Subjects
dc:subject × 22- Καρκίνος όρχεων
- Όγκοι από γεννητικά κύτταρα
- Αγγειογένεση
- Απόπτωση
- Ινσουλινοειδής αυξητικός παράγοντας
- Μεταλλοπρωτεϊνάσες
- Αγγειοποιητίνη
- Αγγειακός ενδοθηλιακός αυξητικός παράγοντας (VEGF)
- Testicular cancer
- Germ cell tumours
- Angiogenesis
- Apoptosis
- Insulin like growth factors (IGF)
- Metalloproteinases
- Angiopoietin
- Vascular endothelial growth factor (VEGF)
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Clinical Medicine
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28273